Karen L. Smith, Director at Aurinia Pharmaceuticals Inc. (AUPH), sold 5,241 shares at $8.43 ($44K) on 2024-11-11, disclosed to the SEC on 2024-11-12.
Open-market sale of $44k AUPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | BUY | 2016-08-12 | $167K | — | Filing → |
| JAZZ | BUY | 2016-07-13 | $167K | — | Filing → |
| JAZZ | BUY | 2016-06-15 | $167K | — | Filing → |